TY - JOUR
T1 - Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin
T2 - In vitro results and in vivo effects in an acute rejection model
AU - Tazzari, P. L.
AU - Polito, L.
AU - Bolognesi, A.
AU - Pistillo, M. P.
AU - Capanni, P.
AU - Palmisano, G. L.
AU - Lemoli, R. M.
AU - Curti, A.
AU - Biancone, L.
AU - Camussi, G.
AU - Conte, R.
AU - Ferrara, G. B.
AU - Stirpe, F.
PY - 2001/10/15
Y1 - 2001/10/15
N2 - Immunotoxins containing recombinant human-derived single-chain fragment variable (scFv) reagents (83 and 40) against CTLA-4 (CD152) linked to saporin, a ribosome-inactivating protein, were prepared and tested on CD3/CD28-activated T lymphocytes, MLRs, CTLA-4-positive cell lines, and hemopoietic precursors. Immunotoxins induced apoptosis in activated T lymphocytes and were able to specifically inhibit MLR between T lymphocytes and dendritic cells. The 83-saporin immunotoxin also inhibited the T cell activation in an MLR between T lymphocytes and an EBV-positive lymphoblastoid B cell line. Toxicity tests on hemopoietic precursors showed little or no effects in inhibiting colonies' growth. As the 83 scFv Ab was reactive also with activated mouse T lymphocytes, 83-saporin was tested in a model of tumor rejection consisting of C57BL/6 mice bearing a murine H.end endothelioma cell line, derived from DBA/2 mice. The lymphoid infiltration due to the presence of the tumor was reduced to a high extent, demonstrating that the immunotoxin was actually available and active in vivo. Thus, taking the results altogether, this study might represent a new breakthrough for immunotherapy, showing the possibility of targeting CTLA-4 to kill activated T cells, using conjugates containing scFv Abs and type 1 ribosome-inactivating protein.
AB - Immunotoxins containing recombinant human-derived single-chain fragment variable (scFv) reagents (83 and 40) against CTLA-4 (CD152) linked to saporin, a ribosome-inactivating protein, were prepared and tested on CD3/CD28-activated T lymphocytes, MLRs, CTLA-4-positive cell lines, and hemopoietic precursors. Immunotoxins induced apoptosis in activated T lymphocytes and were able to specifically inhibit MLR between T lymphocytes and dendritic cells. The 83-saporin immunotoxin also inhibited the T cell activation in an MLR between T lymphocytes and an EBV-positive lymphoblastoid B cell line. Toxicity tests on hemopoietic precursors showed little or no effects in inhibiting colonies' growth. As the 83 scFv Ab was reactive also with activated mouse T lymphocytes, 83-saporin was tested in a model of tumor rejection consisting of C57BL/6 mice bearing a murine H.end endothelioma cell line, derived from DBA/2 mice. The lymphoid infiltration due to the presence of the tumor was reduced to a high extent, demonstrating that the immunotoxin was actually available and active in vivo. Thus, taking the results altogether, this study might represent a new breakthrough for immunotherapy, showing the possibility of targeting CTLA-4 to kill activated T cells, using conjugates containing scFv Abs and type 1 ribosome-inactivating protein.
UR - http://www.scopus.com/inward/record.url?scp=0035887785&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035887785&partnerID=8YFLogxK
M3 - Article
C2 - 11591743
AN - SCOPUS:0035887785
VL - 167
SP - 4222
EP - 4229
JO - Journal of Immunology
JF - Journal of Immunology
SN - 0022-1767
IS - 8
ER -